Intra-Cellular Therapies Inc.

Q2 2021 13F Holders

Symbol
ITCI
CUSIP
46116X101
Type
Equity
Class
COM
Num filers
192
Total reported value, excl. options
$2.74B
Manager Report Date Value ($000) Shares Option Type